Introduction
Supercoiled plasmid DNA has emerged as a suitable drug substrate which can be easily employed for the detection of drug-DNA interactions [1, 2] . The double helix in supercoiled plasmids are covalently linked in "end-to-end" fashion, and, the normal base-pair twist angle becomes reduced from its optimal value of ~ 36° resulting in the formation of a second, higher-order helix, which is known as the super helix (commonly referred to as supercoiled DNA, SC or Form I). DNA-interacting substrates can bind to super helical DNA and mechanically, or chemically reduce the number of super-helical turns which has the net effect of converting this secondary structure into an "open circular" form (OC or Form II). Metal-containing reagents that chemically modify supercoiled DNA are often referred to as artificial metallonucleases, and, in some instances these agents can induce a further modification to open circular DNA by converting it into a "linear" conformation (LC or Form III). Reagents, such as the clinical antitumor drug cisplatin (cis-[Pt(NH 3 ) 2 Cl 2 ]), can mechanically convert super helical DNA from Form I → Form II by cross-linking (alkylating) intrastrand guanine bases which, in-turn, reduces the amount of supercoiling in the plasmid [2] . Additionally, artificial metallonucleases such as the activated form of the clinical chemotherapeutic agent bleomycin (BLM), [Fe 2+ BLM or Cu 2+ BLM], are known to tightly bind to DNA before inducing chemical scission of the deoxyribose ring through the formation of reactive oxygen radicals [3] . The mode of action of metal-bound BLM results in both the cleavage of a single strand of DNA (Form I → Form II) and of the double strand (Form I → Form III) and it has previously been established that the induction of double-strand damage parallels the drug concentration dependence for inhibition of cell proliferation [4] . Given the activity both these clinical agents display toward super helical DNA, there has been sustained interest in the design of new metal-based therapeutics which are also capable of modifying this drug substrate.
The DNA cleavage properties of the synthetic chemical nuclease, [Cu(phen) 2 ] 2+ (phen = 1,10-phenanthroline), is dependent on the presence of both exogenous reductant (e.g. L-ascorbic acid) and oxidant (e.g., O 2 or H 2 O 2 ) [5] . Recently, we have reported the first self-cleaving dinuclear bis-phen system, [{Cu{(phen) 2 } 2 (terph)] (terph)13.5H 2 O.2EtOH [6] , containing the active cation [{Cu(phen) 2 } 2 (terph)] 2+ , which is capable of inducing single-stranded DNA scission in the absence of exogenous reductant. This agent also displays significant in vitro chemotherapeutic potential against breast cancer (MCF-7), prostate cancer (DU145) and colon cancer (HT29) cells. Additionally, we have recently reported a water-soluble DNA dinuclear cleaving variant, Cu 2+ bis-phen octanedioate [7] , which displays unprecedented nano-and picomolar in vitro cytotoxicity against human-derived colorectal cancer lines (HT29, SW480 and SW620).
In order to expand our knowledge of the DNA cleavage capabilities of these dinuclear cytotoxic agents, we have examined the interaction of [{Cu(phen) 2 } 2 (terph)] 2+ , across the concentration range 1 -50 mM, with supercoiled pUC18 plasmid DNA over the time period of 20 h at 37 °C in the absence of exogenous reagents. Additionally, we report the interaction of this same agent, at a fixed concentration of 10 mM, over a reduced time frame of 2 h in the presence of co-reactants, hydrogen peroxide (H 2 O 2 ) and L-ascorbate.
Material and methods

Drugs and reagents
The complex [{Cu{(phen) 2 } 2 (terph)] (terph)13.5H 2 O.2EtOH was prepared and characterized according to the literature method [7] . Supercoiled plasmid DNA, pUC18, was supplied by Roche Diagnostics Limited, U.K.. All other reagents were supplied by Sigma-Aldrich, Ireland and used without further purification.
DNA Cleavage Reactions
Reactions in the absence of added reductant or oxidant Experiments were carried out in a total volume of 15 ml in 0.1 M cacodylate buffer (pH = 6.0) with 1 -50 mM of the complex, which was initially prepared in DMF, then diluted in buffer (in which it dissolved), with 1 ml of 0.25 mg/ml pUC18. Samples were incubated for 20 h at 37 o C. Quench buffer (3 ml; 0.25% bromophenolblue, 0.25% xylene cyanole and 30% glycerol) was then added and samples were loaded onto agarose gel (1%) containing 1.5 ml of GelRed TM (10,000×). Electrophoresis was completed at 80 V for 2 h in 1× TAE buffer.
Reactions in the presence of oxidant and reductant
Experiments were carried out in a total volume of 20 µl in cacodylate buffer (pH = 6.0) with 10 µM of the complex which was initially prepared in DMF then diluted in buffer (in which it dissolved), with 1 µl of 0.25 µg/µl pUC18 along with either 20 µM of hydrogen peroxide (H 2 O 2 ) or 50 µM sodium L-ascorbate or a combination thereof. Samples were incubated for 2 h at 37 o C. Quench buffer (3 ml; 0.25% bromophenolblue, 0.25% xylene cyanole and 30% glycerol) was then added and samples were loaded onto agarose gel (1%) containing 1.5 ml of GelRed TM (10,000 ×). Electrophoresis was completed at 80 V for 2 h in 1 × TAE buffer.
Results
The development of new DNA-targeting agents is of importance to cancer chemotherapy because of their potential to (i) increase effectiveness, (ii) offer enhanced tolerance and (iii) circumvent resistance to the clinically established drugs. Previously we have demonstrated that the agent [{Cu(phen) 2 } 2 (terph)] 2+ is capable of inducing low-micromolar (~ 6 µM) in vitro toxicity toward a range of cancer cells within a relatively short timeframe (24 h) [6] . We have also shown that this cationic agent has significant binding affinity to calf-thymus DNA and that it can induce detectable single stranded DNA scission (Form I → Form II) over a 5 h time period. To extend these studies, questions arose on how this agent may interact with plasmid DNA over a prolonged period of time (e.g. 24 h) and also on whether any cleavage enhancement could be detected in the presence of exogenous co-factors (e.g. oxidant and/or reductant). Relaxation of supercoiled (SC) pUC18 DNA (Form I) into open circular (OC, Form II) and linear (LC, Form III) conformations was used to quantify the relative cleavage efficiency of the tested complex. Incubation of pUC18 with the agent in the absence of added cofactors resulted in a concentration-dependent relaxation of SC (Form I) into OC (Form II) over a 20 h period (Figure 1a) . The agent was found to induce almost complete conversion of Form I → Form II at a concentration of 5 µM, a result which appears significant in the context of its cytotoxic IC 50 values. At a concentration of 10 µM, over a reduced time-frame of 2 h, an enhancement in the conversion rate of Form I → Form II was evident in the presence of 20 µM H 2 O 2 (Figure 1b, Lane 2) . This result may implicate the role of reactive oxygen species within the scission profile of this reagent. Upon addition of the reductant ascorbate (50 µM), a further enhancement followed with complete depletion of the SC DNA band (Form I) being witnessed alongside a minor conversion to OC (Form II) and a major conversion to LC (Form III) (Figure 1b, Lane 3) . It is widely believed that reduction of the copper(II) species in [Cu(phen) 2 ] 2+ to [Cu(phen) 2 ] + by ascorbate, or other such exogenous reductants, is essential to the DNA activating mechanism of that particular agent. In this context, it is not surprising that the cleavage reaction of the terephthalate agent is significantly enhanced upon the addition of ascorbate. Finally, upon exposure of the agent to SC DNA in the presence of both 20 µM of H 2 O 2 and 50 µM of ascorbate, complete degradation of DNA was observed by the complete disappearance of a detectable band (Figure 1b, Lane 4) .
Conclusion
In summary, we have elucidated the DNA cleavage reactions of the cytotoxic agent [{Cu{(phen) 2 } 2 (terph)](terph)13.5H 2 O.2EtOH. Upon prolonged exposure to supercoiled plasmid (pUC18), ~ 5 µM of the agent is required to completely convert the supercoiled (SC) form to its open circular (OC) conformation. An enhancement was found in the presence of exogenous oxidant (H 2 O 2 ) where a faster conversion rate was observed within a 2 h exposure window. Addition of exogenous reductant (ascorbate) delivers a further improvement and results in a majority conversion of SC plasmid to its linear form (LC), indicating the advent of double stranded DNA scission. Finally, in the presence of both oxidant and reductant complete degradation of the plasmid was witnessed. Taken together, these results support the impressive anticancer activity shown by this cytotoxic agent and underpin its potential mode of action.
